Research Article
Recurrent Ischemic and Hemorrhagic Stroke in Cameroon: A Case-Control Study
Table 2
Fisher’s exact and odds ratios of sociodemographic, clinical, and therapeutic factors associated with stroke recurrence.
| Factor | Odds ratio | 95% confidence interval | value |
| Male | 0.68 | 0.27–1.73 | 0.49 | Urban dwelling | 1.04 | 0.40–2.67 | 0.94 | Right handedness | 0.23 | 0.16–0.33 | 0.02 |
| Personal history | Alcohol consumption | 2.26 | 0.89–5.77 | 0.11 | Tobacco consumption | 1.81 | 0.59–5.54 | 0.36 | Sedentary lifestyle | 1.28 | 0.50–3.28 | 0.65 | Chronic kidney disease | 0.73 | 0.08–6.85 | 0.98 | Congestive heart failure | 3.45 | 1.16–10.28 | 0.03 | Diabetes | 2.21 | 0.79–6.20 | 0.16 | Gout | 4.44 | 1.09–18.09 | 0.04 | Hypertension | 1.40 | 0.50–3.97 | 0.62 | Family history of stroke | 1.34 | 0.50–3.60 | 0.61 |
| Presenting signs | Alternating hemiplegia | 0.91 | 0.27–3.09 | 0.98 | Aphasia | 0.30 | 0.06–1.39 | 0.14 | Cerebellar syndrome | 1.61 | 0.14–18.66 | 0.57 | Dysarthria | 4.34 | 1.30–14.54 | 0.02 | Facial palsy | 3.96 | 1.49–10.51 | 0.01 | Intracranial hypertension | 0.31 | 0.04–2.54 | 0.44 | Meningeal syndrome | 0.74 | 0.66–0.84 | 0.57 |
| Medication observance | Antidepressant | N/A | N/A | N/A | Antidiabetic | 3.20 | 0.23–45.19 | 0.55 | Antihypertensive | 0.64 | 0.24–1.72 | 0.47 | Aspirin | 0.79 | 0.10–6.50 | 0.98 | Statin | 0.88 | 0.67–1.14 | 0.98 |
|
|